CUSIP: 03842B101
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,974,112
-
Share change
-
+9,010,527
-
Total reported value
-
$182,543,000
-
Price per share
-
$14.07
-
Number of holders
-
31
-
Value change
-
+$134,059,664
-
Number of buys
-
24
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 03842B101:
Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q3 2015
As of 30 Sep 2015,
AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,974,112 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, FRANKLIN RESOURCES INC, Redmile Group, LLC, BlackRock Advisors LLC, FIRST MANHATTAN CO, BlackRock Group LTD, Cormorant Asset Management, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.